Emma Eriksson
- Telefon:
- 018-471 45 23
- E-post:
- emma.ch.eriksson@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
Publikationer
Senaste publikationer
-
Ingår i Clinical Cancer Research, s. 3157-3168, 2026
-
Ingår i Nature Communications, 2026
- DOI för LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial
- Ladda ner fulltext (pdf) av LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial
-
Ingår i Biomarker Research, 2026
- DOI för Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
- Ladda ner fulltext (pdf) av Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
-
Ingår i Journal of Cellular and Molecular Medicine, 2024
- DOI för CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling
- Ladda ner fulltext (pdf) av CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling
-
Ingår i Genes, 2024
- DOI för Transferability of Human and Environmental Microbiome on Clothes as a Tool for Forensic Investigations
- Ladda ner fulltext (pdf) av Transferability of Human and Environmental Microbiome on Clothes as a Tool for Forensic Investigations
Alla publikationer
Artiklar i tidskrift
-
Ingår i Clinical Cancer Research, s. 3157-3168, 2026
-
Ingår i Nature Communications, 2026
- DOI för LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial
- Ladda ner fulltext (pdf) av LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial
-
Ingår i Biomarker Research, 2026
- DOI för Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
- Ladda ner fulltext (pdf) av Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
-
Ingår i Journal of Cellular and Molecular Medicine, 2024
- DOI för CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling
- Ladda ner fulltext (pdf) av CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling
-
Ingår i Genes, 2024
- DOI för Transferability of Human and Environmental Microbiome on Clothes as a Tool for Forensic Investigations
- Ladda ner fulltext (pdf) av Transferability of Human and Environmental Microbiome on Clothes as a Tool for Forensic Investigations
-
Ingår i The Lancet Oncology, s. 488-500, 2024
-
Ingår i Journal of Translational Medicine, 2023
- DOI för Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models
- Ladda ner fulltext (pdf) av Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models
-
Ingår i MOLECULAR THERAPY-ONCOLYTICS, s. 429-442, 2022
- DOI för Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition
- Ladda ner fulltext (pdf) av Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition
-
Ingår i MOLECULAR THERAPY-ONCOLYTICS, s. 508-518, 2021
- DOI för Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes
- Ladda ner fulltext (pdf) av Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes
-
Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up
Ingår i Frontiers in Veterinary Science, 2021
- DOI för Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up
- Ladda ner fulltext (pdf) av Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up
-
Ingår i Cancer Immunology and Immunotherapy, s. 2851-2865, 2021
- DOI för Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
- Ladda ner fulltext (pdf) av Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
-
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Ingår i Cancer Gene Therapy, s. 948-959, 2020
- DOI för Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
- Ladda ner fulltext (pdf) av Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
-
Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
Ingår i BMC Cancer, 2019
- DOI för Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
- Ladda ner fulltext (pdf) av Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
-
Ingår i Journal of Immunology, s. 787-798, 2019
-
Immunostimulatory gene therapy enhances PD-1 blockade antibody therapy in experimental lung cancer
Ingår i CANCER IMMUNOLOGY RESEARCH, 2018
-
Ingår i Journal of Translational Medicine, 2017
- DOI för Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
- Ladda ner fulltext (pdf) av Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
-
Ingår i Oncotarget, s. 78573-78587, 2017
- DOI för Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients
- Ladda ner fulltext (pdf) av Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients
-
Ingår i Clinical Cancer Research, s. 5846-5857, 2017
-
An oncolytic virus targeting desmoplasia and immune activation in pancreatic cancer
Ingår i Scandinavian Journal of Immunology, s. 335-335, 2017
-
Ingår i Scandinavian Journal of Immunology, s. 337-337, 2017
-
Activating CD40 While Inhibiting IL6R Induces Cytokine Production without PDL1 Upregulation in DCs
Ingår i Molecular Therapy, s. 54-54, 2017
-
Ingår i Gene Therapy, s. 92-103, 2017
- DOI för Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
- Ladda ner fulltext (pdf) av Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
-
Ingår i Journal of Translational Medicine, 2016
- DOI för Gemcitabine reduces MDSCs, tregs and TGF beta-1 while restoring the teff/treg ratio in patients with pancreatic cancer
- Ladda ner fulltext (pdf) av Gemcitabine reduces MDSCs, tregs and TGF beta-1 while restoring the teff/treg ratio in patients with pancreatic cancer
-
Ingår i Molecular Therapy, 2016
-
Ingår i Molecular Therapy, 2016
-
Ingår i Cancer Research, 2015
-
Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
Ingår i PLOS ONE, 2015
- DOI för Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
- Ladda ner fulltext (pdf) av Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
-
Ingår i Gene Therapy, s. 596-601, 2015
-
Development of Gene Transfer Technology
Ingår i Human Gene Therapy, 2014
-
Ingår i Molecular Therapy, 2014
-
Ingår i Molecular Therapy, 2014
-
Ingår i Molecular Therapy, 2014
-
Ingår i Cancer Immunology and Immunotherapy, s. 273-282, 2014
-
Tim-3 and PD-1: Regulators of adaptive immunity in multiple sclerosis
Ingår i Journal of Neuroimmunology, s. 141-141, 2014
-
Ingår i Journal of Neuroimmunology, s. 153-159, 2014
-
Ingår i PLOS ONE, 2013
- DOI för Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
- Ladda ner fulltext (pdf) av Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
-
Ingår i Journal of immunotherapy (1997), s. 350-358, 2013